Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Enliven Therapeutics, Inc. (ELVN) had Current Ratio of 28.66 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-103.69M |
|
-- |
|
-- |
|
$119.66M |
|
$-119.66M |
|
$15.96M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-119.66M |
|
$-119.62M |
|
56.66M |
|
56.66M |
|
$-1.83 |
|
$-1.83 |
|
| Balance Sheet Financials | |
$474.88M |
|
$0.03M |
|
$1.29M |
|
$476.17M |
|
$16.57M |
|
-- |
|
-- |
|
$16.57M |
|
$459.60M |
|
$459.60M |
|
$459.60M |
|
59.44M |
|
| Cash Flow Statement Financials | |
$-70.30M |
|
$-173.84M |
|
$218.87M |
|
$124.17M |
|
$98.90M |
|
$-25.27M |
|
$34.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
28.66 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-70.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.56% |
|
-22.56% |
|
-21.78% |
|
-22.56% |
|
$7.73 |
|
$-1.24 |
|
$-1.24 |
|